We are live on ! Find out more
PROK icon

ProKidney
PROK

80 hedge funds and large institutions have $232M invested in ProKidney in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 11

2.04% more ownership

Funds ownership: 89.42% → 91.45% (+2%)

4% more capital invested

Capital invested by funds: $223M → $232M (+$9.22M)

11% less funds holding

Funds holding: 90 → 80 (-10)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

Holders
80
Holders Change
-10
Holders Change %
-11.11%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
22
Reduced
11
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$10.1M
2
ACA
Arena Capital Advisors
California
+$7.27M
3
6CM
683 Capital Management
New York
+$4.93M
4
HSBC Holdings
HSBC Holdings
United Kingdom
+$4.39M
5
Millennium Management
Millennium Management
New York
+$4.33M

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$10.9M
2
FC
Finepoint Capital
Massachusetts
-$9.7M
3
RIA
RP Investment Advisors
Ontario, Canada
-$5.33M
4
LCM
LH Capital Markets
New York
-$4.95M
5
Franklin Resources
Franklin Resources
California
-$3.96M
Name Holding Trade Value Shares
Change 		Change in
Stake
SIA
26
Schechter Investment Advisors
Michigan
$2.92M +$2.54M +257,847 +692%
WA
27
Whitebox Advisors
Minnesota
$2.48M – – –
MCM
28
Moore Capital Management
New York
$2.47M – – –
IPCP
29
Iron Park Capital Partners
New York
$2.33M +$2.32M +234,800 New
MA
30
MYDA Advisors
New York
$2.3M – – –
GCM
31
Ghisallo Capital Management
Massachusetts
$2.22M – – –
SCM
32
Saba Capital Management
New York
$2.13M -$343K -34,737 -14%
SMA
33
Sage Mountain Advisors
Georgia
$1.99M +$1.25M +127,141 +172%
APM
34
Avidity Partners Management
Texas
$1.98M – – –
DKCM
35
Davidson Kempner Capital Management
New York
$1.98M – – –
AA
36
AQR Arbitrage
Connecticut
$1.89M – – –
Marshall Wace
37
Marshall Wace
United Kingdom
$1.86M +$1.34M +135,913 +256%
BI
38
Bulldog Investors
New Jersey
$1.79M -$82.9K -8,408 -4%
VI
39
Vestcor Inc
New Brunswick, Canada
$1.73M – – –
PAMP
40
Polar Asset Management Partners
Ontario, Canada
$1.68M – – –
WCM
41
Whitefort Capital Management
New York
$1.59M – – –
HF
42
HRT Financial
New York
$1.49M +$754K +76,478 +102%
Jane Street
43
Jane Street
New York
$1.49M +$2.59K +263 +0.2%
CCM
44
Context Capital Management
California
$1.48M +$493K +50,000 +50%
FTCM
45
Fir Tree Capital Management
New York
$1.43M +$1.23M +124,988 +626%
PSAMP
46
P. Schoenfeld Asset Management (PSAM)
New York
$1.43M – – –
RCM
47
Radcliffe Capital Management
Pennsylvania
$1.24M – – –
BCM
48
BlueCrest Capital Management
Jersey
$1.24M +$55.4K +5,619 +5%
CPM
49
Crescent Park Management
California
$1.19M +$103K +10,427 +10%
AGC
50
Angelo Gordon & Co
New York
$990K – – –
1
2
3 4 5

PROK Hedge Fund Activity: Q1 2022 in Review

80 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2022, worth a combined $232M — up 4.1% from $223M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PROK and 14 opened new positions — a net loss of 10 holders — while 11 trimmed existing stakes and 22 added.

The largest buyer was Citadel Advisors, adding an estimated $10.1M. The largest seller was Park West Asset Management, exiting entirely with an estimated $10.9M sold.

  • 80 institutional investors held ProKidney (PROK) as of Q1 2022, down from 90 in Q4 2021.
  • Funds reported $232M of ProKidney stock for Q1 2022, up 4.1% quarter-over-quarter.
  • 14 funds opened new ProKidney positions in Q1 2022 and 24 closed out, a net change of -10 holders.
  • The largest ProKidney buyer in Q1 2022 was Citadel Advisors, an estimated $10.1M added.
  • The largest ProKidney seller in Q1 2022 was Park West Asset Management, an estimated $10.9M sold.

Based on aggregated 13F filings for Q1 2022.